Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Accumulated Expenses (2022 - 2025)

Praxis Precision Medicines (PRAX) has 4 years of Accumulated Expenses data on record, last reported at $35.0 million in Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 47.43% year-over-year to $35.0 million; the TTM value through Dec 2025 reached $35.0 million, up 47.43%, while the annual FY2025 figure was $35.0 million, 47.43% up from the prior year.
  • Accumulated Expenses reached $35.0 million in Q4 2025 per PRAX's latest filing, up from $21.6 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $35.0 million in Q4 2025 and bottomed at $7.0 million in Q1 2024.
  • Average Accumulated Expenses over 4 years is $16.3 million, with a median of $15.5 million recorded in 2025.
  • Peak YoY movement for Accumulated Expenses: plummeted 60.98% in 2023, then soared 220.43% in 2024.
  • A 4-year view of Accumulated Expenses shows it stood at $15.8 million in 2022, then crashed by 53.21% to $7.4 million in 2023, then skyrocketed by 220.43% to $23.8 million in 2024, then soared by 47.43% to $35.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $35.0 million in Q4 2025, $21.6 million in Q3 2025, and $19.0 million in Q2 2025.